These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 21864256)
1. The release and induced immune responses of a plant-made and delivered antigen in the mouse gut. Pelosi A; Shepherd R; Guzman GD; Hamill JD; Meeusen E; Sanson G; Walmsley AM Curr Drug Deliv; 2011 Nov; 8(6):612-21. PubMed ID: 21864256 [TBL] [Abstract][Full Text] [Related]
2. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice. Hongli L; Xukui L; Ting L; Wensheng L; Lusheng S; Jin Z Hum Vaccin Immunother; 2013 Jan; 9(1):83-9. PubMed ID: 23108357 [TBL] [Abstract][Full Text] [Related]
3. The immune response of two microbial antigens delivered intradermally, sublingually, or the combination thereof. Lee S; Picking WL; Tzipori S Microbes Infect; 2014 Sep; 16(9):796-803. PubMed ID: 25111827 [TBL] [Abstract][Full Text] [Related]
4. Use of inactivated Escherichia coli enterotoxins to enhance respiratory mucosal adjuvanticity during vaccination in swine. Barrette RW; Szczepanek SM; Rood D; Challa S; Avery N; Vajdy M; Kramer E; Rodriguez L; Silbart LK Clin Vaccine Immunol; 2011 Nov; 18(11):1996-8. PubMed ID: 21918121 [TBL] [Abstract][Full Text] [Related]
5. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621 [TBL] [Abstract][Full Text] [Related]
6. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers. Stephenson I; Zambon MC; Rudin A; Colegate A; Podda A; Bugarini R; Del Giudice G; Minutello A; Bonnington S; Holmgren J; Mills KH; Nicholson KG J Virol; 2006 May; 80(10):4962-70. PubMed ID: 16641287 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of different promoter sequences and antigen sorting signals on the immunogenicity of Bacillus subtilis vaccine vehicles. Paccez JD; Nguyen HD; Luiz WB; Ferreira RC; Sbrogio-Almeida ME; Schuman W; Ferreira LC Vaccine; 2007 Jun; 25(24):4671-80. PubMed ID: 17498854 [TBL] [Abstract][Full Text] [Related]
8. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice. Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244 [TBL] [Abstract][Full Text] [Related]
9. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax. Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Tacket CO; Pasetti MF; Edelman R; Howard JA; Streatfield S Vaccine; 2004 Oct; 22(31-32):4385-9. PubMed ID: 15474732 [TBL] [Abstract][Full Text] [Related]
11. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli. Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Tacket CO; Mason HS; Losonsky G; Clements JD; Levine MM; Arntzen CJ Nat Med; 1998 May; 4(5):607-9. PubMed ID: 9585236 [TBL] [Abstract][Full Text] [Related]
13. Transgenic plants expressing a Clostridium difficile spore antigen as an approach to develop low-cost oral vaccines. Rosales-Mendoza S; Cervantes-Rincón T; Romero-Maldonado A; Monreal-Escalante E; Nieto-Gómez R Biotechnol Prog; 2021 May; 37(3):e3141. PubMed ID: 33666366 [TBL] [Abstract][Full Text] [Related]
14. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants. Nawar HF; Arce S; Russell MW; Connell TD Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982 [TBL] [Abstract][Full Text] [Related]
15. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Katz DE; DeLorimier AJ; Wolf MK; Hall ER; Cassels FJ; van Hamont JE; Newcomer RL; Davachi MA; Taylor DN; McQueen CE Vaccine; 2003 Jan; 21(5-6):341-6. PubMed ID: 12531630 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD. Heine SJ; Diaz-McNair J; Martinez-Becerra FJ; Choudhari SP; Clements JD; Picking WL; Pasetti MF Vaccine; 2013 Jun; 31(28):2919-29. PubMed ID: 23644075 [TBL] [Abstract][Full Text] [Related]
17. The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens. Leach S; Clements JD; Kaim J; Lundgren A PLoS One; 2012; 7(12):e51718. PubMed ID: 23284753 [TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin. Ruedl C; Rieser C; Kofler N; Wick G; Wolf H Vaccine; 1996 Jun; 14(8):792-8. PubMed ID: 8817827 [TBL] [Abstract][Full Text] [Related]
19. The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine. Jones FR; Hall ER; Tribble D; Savarino SJ; Cassels FJ; Porter C; Meza R; Nunez G; Espinoza N; Salazar M; Luckett R; Scott D Vaccine; 2006 May; 24(18):3786-92. PubMed ID: 16343702 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin. Luo Q; Vickers TJ; Fleckenstein JM Clin Vaccine Immunol; 2016 Jul; 23(7):628-37. PubMed ID: 27226279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]